DOLISHALE 90-20 MCG TABLET
FDA nonproprietary name: levonorgestrel and ethinyl estradiol
For 30 tablets
Pharmacies pay
$34.07 filed
30 × $1.13572 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$34.26 filed
30 × $1.1421 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
1.0× estimated
Medicare paid about what pharmacies pay.
Part D averages every strength and form sold under “Dolishale” / “Levonorgestrel/Ethin.Estradiol” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$44.18 estimated
$34.07 + $5.11 (15%) + $5.00 fee per fill = $44.18
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
DOLISHALE 90-20 MCG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as levonorgestrel and ethinyl estradiol, under the trade name “Dolishale”.
FDA gives its dosage form as tablet and its route as oral.
The labeler, the company named on the label, is Ingenus Pharmaceuticals, LLC.
FDA lists it under 3 Established Pharmacologic Classes: Estrogen, Progestin and Progestin-containing Intrauterine System.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $34.07 for 30 tablets (30 × $1.13572 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
All 2 NDCs
- 50742-0659-28 · Ingenus Pharmaceuticals, LLC · $1.13572 per EA · eff. 2026-09-23 filed
- 50742-0659-84 · Ingenus Pharmaceuticals, LLC · $1.13572 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
22 other products in the NADAC file share the FDA nonproprietary name levonorgestrel and ethinyl estradiol with DOLISHALE 90-20 MCG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ALTAVERA-28 TABLET | $0.11352 per EA filed | $0.35078 per EA filed |
| AMETHYST 90-20 MCG TABLET | $1.13572 per EA filed | $1.30648 per EA filed |
| AUBRA EQ-28 TABLET | $0.15354 per EA filed | $0.40572 per EA filed |
| AVIANE-28 TABLET | $0.15354 per EA filed | $0.38721 per EA filed |
| AYUNA-28 TABLET | $0.11352 per EA filed | We don’t know yet |
| BALCOLTRA TABLET | $10.03814 per EA filed | $9.45799 per EA filed |
| CHATEAL EQ-28 TABLET | $0.11352 per EA filed | $0.4374 per EA filed |
| DAYSEE 0.15-0.03-0.01 MG TAB | $0.12477 per EA filed | $0.58271 per EA filed |
| DOLISHALE 90-20 MCG TABLET this page | $1.13572 per EA filed | $1.1421 per EA filed |
| FALMINA-28 TABLET | $0.15354 per EA filed | $0.39865 per EA filed |
| KURVELO-28 TABLET | $0.11352 per EA filed | $0.38666 per EA filed |
| LESSINA-28 TABLET | $0.15354 per EA filed | $0.38762 per EA filed |
| LEVONEST-28 TABLET | $0.32363 per EA filed | $0.56482 per EA filed |
| LEVONOR-ETH ESTRA 0.09-0.02 MG | $1.13572 per EA filed | We don’t know yet |
| LEVONOR-ETH ESTRAD 0.1-0.02 MG | $0.15354 per EA filed | We don’t know yet |
| LEVONOR-ETH ESTRAD TRIPHASIC | $0.32363 per EA filed | We don’t know yet |
| LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET | $0.22674 per EA filed | We don’t know yet |
| LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB | $3.44543 per EA filed | We don’t know yet |
| MARLISSA-28 TABLET | $0.11352 per EA filed | $0.37153 per EA filed |
| PORTIA-28 TABLET | $0.11352 per EA filed | $0.34264 per EA filed |
| SETLAKIN 0.15 MG-0.03 MG TAB | $0.22674 per EA filed | $0.50192 per EA filed |
| TYBLUME 0.1-0.02 MG CHEW TAB | $0.82769 per EA filed | $0.77059 per EA filed |
| VIENVA-28 TABLET | $0.15354 per EA filed | $0.37383 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 2 NDCs’ NADAC prices is $1.13572 per EA filed.
Of the 104 other products in FDA’s Estrogen class priced per EA, 77 have a higher middle NADAC price and 25 a lower one; 2 have the same. The one in the middle is DOTTI 0.0375 MG PATCH, at $8.26227 per EA filed (eff. 2026-09-23).
Of the 65 other products in FDA’s Progestin class priced per EA, 26 have a higher middle NADAC price and 37 a lower one; 2 have the same. The one in the middle is NORETHIN-ETH ESTRAD 1 MG-5 MCG, at $0.57994 per EA filed (eff. 2026-09-23).
Of the 9 other products in FDA’s Progestin-containing Intrauterine System class priced per EA, 7 have a higher middle NADAC price and 0 a lower one; 2 have the same. The one in the middle is MY WAY 1.5 MG TABLET, at $6.33055 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $34.26 for 30 tablets, at an average of $1.1421 per EA in 2024 (2024-01-01 to 2024-12-31) for “Dolishale” and “Levonorgestrel/Ethin.Estradiol”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 219 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for DOLISHALE 90-20 MCG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Dolishale / Levonorgestrel/Ethin.Estradiol: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
Related pages
Its pharmacologic classes
Related in the same class
- CLIMARA PRO PATCH
- TWIRLA 120-30 MCG/DAY PATCH
- PREMPRO 0.3 MG-1.5 MG TABLET
- ABIGALE 1 MG-0.5 MG TABLET
- NORTREL 1-35 21 TABLET